Pfizer Inc. (PFE:NYSE)
Snapshot of Pfizer Inc. (PFE)
|
OPEN
--
|
PREVIOUS CLOSE
$18.36
|
||
|
DAY HIGH
--
|
DAY LOW
--
|
||
|
52 WEEK HIGH
11/20/09 - $18.48
|
52 WEEK LOW
03/2/09 - $11.62
|
||
|
MARKET CAP
148.2B
|
AVERAGE VOLUME 3 mo
43.6M
|
||
|
DILUTED EPS TTM
$1.20
|
SHARES OUTSTANDING
8.1B
|
||
|
EX-DATE
11/4/09
|
P/E TTM
15.3x
|
||
|
DIVIDEND
$0.64
|
DIVIDEND YIELD
3.49%
|
||
| K = Thousands M = Millions B = Billions | |||
BUSINESS EXCHANGE RELATED TOPICPfizer | |||
related business week news
As more U.S. companies send their sophisticated R&D offshore, America must provide worker retraining to maintain its tech leadership
With its long recession finally ending, Germany's biggest city has become a magnet for businesses
With its long recession finally ending, Germany's biggest city has become a magnet for businesses
Following its settlement of kickback allegations with Omnicare, the Justice Dept. continues to probe Johnson & Johnson
related news
PFE Details
Pfizer Inc. engages in the discovery, development, manufacture, and marketing of prescription medicines for humans and animals worldwide. Its Pharmaceutical segment offers Lipitor for elevated cholesterol levels in the blood; Norvasc for hypertension; Caduet for cardiovascular events; Chantix/Champix for smoking cessation; Lyrica for neuropathic pain; Geodon/Zeldox, a psychotropic agent; and Aricept for Alzheimer’s disease. It also provides Celebrex for arthritis pain, and inflammation and acute pain; Vfend for esophageal candidiasis and blood stream infections; Zyvox for bacterial infections; and Selzentry/Celsentri for adults infected with only CCR5-tropic HIV-1 detectable. In addition, this segment provides Viagra for erectile dysfunction; Detrol and Toviaz for overactive bladder; Camptosar for metastatic colorectal cancer; Sutent, an oral multi-kinase inhibitor; Xalatan/Xalacom for open-angle glaucoma and ocular hypertension; and Genotropin for growth disorders. The company’s Animal Health segment offers parasiticides, anti-inflammatories, antibiotics, vaccines, antiemetics, and anti-obesity agents. It also provides Revolution/Stronghold for dogs and cats; Rimadyl for pain and inflammation associated with canine osteoarthritis and soft tissue orthopedic surgery; Clavamox/Synulox for skin and soft tissue infections; RespiSureOne/StellamuneOne to prevent pneumonia in swine; Bovi-Shield Gold for reproductive and respiratory protection; Dectomax, an injectable and pour-on formulations; Draxxin, an antibiotic for infections in cattle and swine; and Excede to treat infections in dairy cows, beef cattle, and swine. Pfizer Inc. also involves in contract manufacturing and bulk pharmaceutical chemicals businesses. It serves doctors, nurse practitioners, physician assistants, pharmacists, hospitals, pharmacy benefit managers, managed care organizations, and government agencies. The company was founded in 1849 and is headquartered in New York, New York.
PFE Top Compensated Officers
Key developments for Pfizer Inc. (PFE)
Pfizer Inc. has announced that its global R&D network, marking an important step in implementing a new R&D model as part of the integration of Pfizer and Wyeth. This global network brings together scientific strengths from both companies, continues efforts to increase research productivity, focuses disease-area research in single locations and more efficiently uses the company's real estate. Pfizer will have five main research sites that will serve as central hubs for research activities in biotherapeutics, pharmatherapeutics and vaccines. These sites are: Cambridge, Massachusetts; Groton, Connecticut; Pearl River, New York; La Jolla, California; and Sandwich, UK. These research-oriented laboratories will be supplemented by specialized research capabilities, such as monoclonal antibody discovery in San Francisco, regenerative medicine work in Cambridge, UK, and R&D activities in Shanghai, China. As part of the consolidation of research sites, Pfizer will significantly reduce R&D activities at some of its sites. In addition, Pfizer will consolidate R&D functions from its New London, Connecticut, site to its nearby research facility in Groton, Connecticut.
Pfizer Inc. has mapped out a new structure for its research and development operations. The plan, will bring the closure of six of the two companies' 20 research facilities, reorganize and consolidate others, and cut the jobs of up to 2,000 scientists and laboratory technicians.
Pfizer Inc. selected Pearl River as one of the five main research sites under its global research and development network. Under the new structure, the Pearl River campus would focus on vaccine and biotherapeutics research. The company also announced that the Rouses Point and Plattsburgh operations would close next year, with Chazy to follow in 2011. Pfizer is also closing research operations in Princeton, N.J., two sites in North Carolina and one in the United Kingdom.
BusinessWeek Rankings
Stock Quotes
| Recently Viewed | |||
| PFE | $18.36 USD | 0.00 |  |
|---|---|---|---|
| SPX (CA) | C$0.07 CAD | 0.00 |  |
| TM | $76.97 USD | 0.00 |  |
| QCOM | $45.10 USD | 0.00 |  |
Market data is delayed at least 20 minutes.
PFE Competitors
| Company | Last | Change |
| Bayer | €52.68 EUR | +0.97 |
| Kraft Foods Inc | $27.17 USD | +0.20 |
| Sanofi - Aventis | €51.11 EUR | +0.74 |
| View Industry Companies | ||
| Market data is delayed at least 20 minutes. | ||
Industry Analysis
| Valuation | PFE | Industry Range |
| Price/Earnings | 15.3x |
|
| Price/Sales | 2.7x |
|
| Price/Book | 2.2x |
|
| Price/Cash Flow | 14.1x |
|
| TEV/Sales | 1.2x |
|
|
PFE |
||
PFE transactions
| Type Date |
Target |
|
Merger/Acquisition
November 9, 2009 |
Pfizer Inc., Chesterfield Village Research Center |
|
Fund Raising
October 26, 2009 |
Mission Bay Capital I, L.P. |
|
Merger/Acquisition
June 22, 2009 |
Monogram Biosciences, Inc. |
Companies Toolbox
Update/report
Submit private company
Upload your company video
Newsletter
Blogs
RSS feeds
Podcasts
VideosSEARCH FOR JOBS
Post a Job- Andover, MA-Pfizer
- La Jolla, CA-Pfizer
- La Jolla, CA-Pfizer
- La Jolla, CA-Pfizer
Jobs by SimplyHired
Recommend A Data Enhancement Or Correction
For Pfizer Inc. (PFE) Snapshot
Submitting this data update / error report instantly puts the correct information in the hands of our researcher, who will investigate your report and, if necessary, make the changes to the company profile. Be sure to fill out the form completely.
Please indicate in which section the error appears. Section headers are in light gray type at the top of each CIC page module.
Please indicate which data is in error.
Please provide your name and email address in case our researchers need to get in touch with you as they investigate the error.
Describe why you feel the data point is incorrect and indicate sources our researchers should check when they investigate the error.
